Shares of Medtronic PLC MDT slid 1.65% to $83.45 Monday, on what proved to be an all-around poor trading session for the ...

The medical robot and pacemaker company isn’t very well known outside of Minnesota, said Mark Smith, vice president for global talent acquisition. Attracting Generation Z, whose members were born ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

The company also has an excellent dividend profile, having raised its payouts for 47 consecutive years. In just three more years, it will join the prestigious clique of Dividend Kings. That makes ...

The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

Former Medtronic chief executive and Harvard Business School executive fellow Bill George calls these times for corporate ...

Shares of Medtronic PLC MDT rose 1.54% to $84.85 Friday, on what proved to be an all-around favorable trading session for the ...

Medtronic's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Read why I am ...

Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...